Ajinomoto Completes Acquisition of Althea Technologies

Article

Ajinomoto Co. Inc. reported the completion of a previously announced acquisition of Althea Technologies.

Ajinomoto Co. Inc. reported the completion of a previously announced acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services.

According to a company statement, Ajinomoto acquired all the capital stock of Althea for a purchase price of approximately $175 million. Althea will become a fully consolidated subsidiary of Ajinomoto Co., Inc. operating under the company name Ajinomoto Althea, Inc.

Ajinomoto Co. is a global manufacturer of seasonings, processed foods, beverages, amino acids, pharmaceuticals, and specialty chemicals. Althea Technologies is a contract development and manufacturing organization located in San Diego, providing clinical and commercial product development services.

 

Recent Videos
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Eswar Iyer, Aikium Inc.
Leroy (Lee) Hood, MD, PhD
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
© 2025 MJH Life Sciences

All rights reserved.